Home Does the use of 3D-printed cones give a chance to postpone the use of megaprostheses in patients with large bone defects in the knee joint?
Article Open Access

Does the use of 3D-printed cones give a chance to postpone the use of megaprostheses in patients with large bone defects in the knee joint?

  • Daniel Kotrych , Sławomir Marcinkowski , Adam Brodecki , Marcin Anuszkiewicz , Jakub Kleszowski , Andrzej Bohatyrewicz and Dawid Ciechanowicz EMAIL logo
Published/Copyright: July 15, 2022

Abstract

Revision procedures and the resulting bone loss are a big challenge for orthopedic surgeons. Therefore, we checked what functional outcomes that 3D-printed cone augments can offer to patients with bone defects (Anderson Orthopedic Research Institute [AORI] classification type 2B and 3) in the knee and whether the use of cones can delay the necessity to use a megaprotheses. Data from 64 patients (M = 22; W = 42) who underwent total knee arthroplasty (TKA) revision were included in the analysis. The Knee Society Clinical Rating System (KSS) and the range of motion in the knee joint were used for the functional assessment. The mean follow-up was 28 months (range: 18–44 months). The survival rate for aseptic loosening at follow-up was 100%. Infection occurred in two (3.1%) patients. The mean KSS score increased from 12.75 points preoperatively to 66.56 postoperatively (p < 0.001). The mean range of motion in the knee changed from 61.15° preoperatively to 115.93° postoperatively (p < 0.001). 3D-printed cone augments seem to be a good solution for patients requiring a TKA revision procedure. When used in patients with bone defects classified as 2B and 3 (AORI), they can be a good alternative, delaying the need for megaprotheses.

1 Introduction

Total knee arthroplasty (TKA) is an effective and commonly used method of treatment for advanced osteoarthritis. All over the world, the number of primary arthroplasty procedures is constantly growing. In 2005, a total of 523,000 joint replacement operations were performed in the United States. It is estimated that this number will increase by 673% to 3,480,000 procedures in 2030 in the United States. The number of revisions in the same year amounted to 38,500 and is expected to increase by over 600% to 268,200 in 2030 in the United States [1,2]. The most common reasons for revision are infections, instability, wrong size and fixation of implants. In the case of late revisions (>2 years from the primary procedure), these are polyethylene wear (34%) and aseptic loosening (24%) [3].

The decision to perform a TKA revision should be considered in many aspects, especially in terms of the expected results. The procedure is associated with a lot of problems. The most important ones are reconstructing bone defects, obtaining a stable and correct component fixation, restoring the joint line, determining the correct traction of the patella and obtaining uniform tension of the collateral ligaments and identical space in the flexion–extension movement [4,5]. The survival of implants after a revision surgery is lower (86% over 10 years) compared to primary surgery (95% over 15 years) [6]. This is due to a more complex clinical situation, mainly related to bone loss and changes in bone density.

The treatment of bone defects has evolved over recent years. Various strategies have been described, mainly depending on the size of the bone defect, including the use of cement, metal augments or bone graft [7]. While the treatment of minor and moderate defects shows good results, treatment methods for major bone defects remain problematic [8], especially in the metaphyseal zone. High hopes can be pinned on the use of cone-type augments, made of porous surfaces, enabling biological integration through bone ingrowth [9]. The aim of this study is to check the clinical results in patients treated surgically with 3D-printed metal cone augments and, in particular, to determine whether the use of metaphyseal augments in patients with type 2 and 3 defects according to Anderson Orthopedic Research Institute (AORI) is a chance to delay the use of resection procedures and megaprotheses.

2 Methods

Between January 2017 and January 2020, a total number of 64 knee arthroplasty revisions were performed with the use of the 3D-printed cone augments. All patients or their relatives gave written informed consent to be included in scientific studies during their admission to the hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards and have been approved by the authors’ institutional review board or equivalent committee.

Qualification for surgery was undertaken independently by orthopedic specialists experienced in TKA revision procedures. The decision on the choice of stem length and method of fixation was made by the surgeons based on planning and intraoperative evaluation.

Patients were reviewed retrospectively. The following factors were assessed: the reason for the revision and the number of previous operations; the number of complications (infections, implant loosening and fracture); and integration of the implant with bone tissue (signs of loosening defined as implant migration or radioactivity ≥2 mm along with the entire component). In addition, the functional assessment of the joint, using The Knee Society Clinical Rating System (KSS), was evaluated. The evaluation was conducted pre- and post-operatively in the twelfth month after the surgery.

The dimensions of the components used and the method of fixation were also checked. The level of bone loss was assessed on the basis of preoperative radiological examinations (CT and X-ray) according to the AORI classification, which is one of the most commonly used scales for assessing bone defects. All radiographs were reviewed by five independent orthopedists.

The results of the KSS were statistically analyzed. After checking the data distribution (the Shapiro–Wilk test), Student’s T-test was performed in relation to the results in the questionnaire and the range of motion in the knee joint. A p-value of <0.05 was considered a statistically significant difference. Statistical analysis was carried out using the Statistica 13.0.2 program.

3 Results

3.1 Demographic data

The study group (n = 64) consisted of 42 women (66%) and 22 men (34%). The mean age of the patients at the time of surgery was 71 years (range: 57–80 years). The mean follow-up was 28 months (range: 18–44 months). In the analyzing group, it was the first revision surgery for 41 (64.1%) patients, 12 (18.8%) patients had two previous operations, 4 (6.2%) patients had three previous operations and 7 (10.9%) patients had four previous operations. In 35 (54.7%) cases, the reason for revision was an incorrect rotation of the endoprosthesis components and pain, loosening in 18 (28.1%) cases, infection in 9 (14.1%) cases and polyethylene wear in 2 (3.1%) cases. Patients who were operated on due to infection underwent a two-stage procedure. The duration between stages was on average 6 weeks (Table 1).

Table 1

Demographic data of patients reconstructed with 3D-printed cone

Data Patients Percentage
Age and gender
Age (mean years) 71 (range: 57–80)
Gender (male/female) 22/42 34/66
Revision surgery
First 41 64.1
Second 12 18.8
Third 4 6.2
Fourth 7 10.9
Reason for revision
Incorrect component rotation 35 54.7
Loosening 18 28.1
Infection 9 14.1
Polyethylene wear 2 3.1

3.2 Surgical outcomes

For the reconstruction of massive bone defects, 3D-printed cone was used, including 38 (59.4%) tibial parts (13 Central and 25 peripheral) and 26 (40.6%) femoral parts. In 13 (20.3%) cases, cones augmentation involved both the femur and the tibia.

Based on the AORI classification, 65.7% of the tibial defects (n = 25) and 7.7% of the femoral defects (n = 2) were classified as type 2B using pre-operative radiographs, computer tomography and intraoperative evaluation, while 34.2% of the tibial bone loss (n = 13) and 92.3% of the femoral bone loss (n = 24) were classified as type 3.

On the tibia side, 64 stems were used, including eight (12.5%) fixed with cement. On the femoral side, 64 stems were used, all uncemented. The length of tibial stems was 100 mm in 49 (76.6%) knees, 50 mm in 8 (12.5%) knees and 150 mm in 7 (10.9%) knees. On the femoral side, all stems were 100 mm long. In one case, a patella prosthesis was implanted. Radiographic analysis showed bone–cone integration in all cases at 98% of the border bone area (Table 2).

Table 2

Summary of operational outcomes in the study group, treated with 3D-printed cones (n = 64)

Data Patients Percentage
3D-printed cone
Tibial part 38 59.4
Femoral part 26 40.6
Both 13 20.3
Bone defects (AORI)
Type 2B 27 42.2
Type 3 37 57.8
Type of fixation
Tibia (cem.1/uncem.2) 8/56 12.5/87.5
Femur (cem.1/uncem.2) 0/64 0/100
Length of the tibial stems
50 mm 8 12.5
100 mm 49 76.6
150 mm 7 10.9
Length of the femoral stems
100 mm 64 100

1cem. – cemented.

2uncem. – uncemented.

3.3 Complications

The survival rate for aseptic loosening at follow-up (28 months) was 100% (95% CI = 95–100%). Deep infection (S. aureus) occurred in two (3.1%) patients 6 weeks after implantation. In our group, a total of 14 (21.9%) patients underwent additional operations. The most common treatments are irrigation and debridement. No intraoperative complications related to cone implantation were reported.

3.4 Functional results

The mean preoperative range of motion in the knee was 61.14545° (±6.059636°). After surgery, it increased by an average of 54.78 points (p < 0.001) to 115.9273° (±6.624462°). The opening mean score in the 100° KSS questionnaire was 12.74545 (±7.506092) points, after the procedure increased by an average of 66.56 points (p < 0.001) to 79.32727 (±3.288896) points (Figure 1).

Figure 1 
                  Comparison of patients’ functional outcomes (KSS questionnaire and range of motion) in the preoperative and 12 months postoperative period.
Figure 1

Comparison of patients’ functional outcomes (KSS questionnaire and range of motion) in the preoperative and 12 months postoperative period.

4 Discussion

Revision procedures after TKA are often a big challenge for surgeons. Additional problems arise especially when large bone defects occur (2B and 3 according to the AORI classification). According to our experience and the available literature, the key to the success of the procedure is appropriate planning, which takes into account, e.g., zonal classification system. It determines three levels of implant fixation: joint surface, metaphysis and diaphysis [10]. Most revision systems achieve stability due to the distribution of loads on the joint surface and diaphysis zones; however, it is in the metaphyseal zone that the greatest forces occur, where their uneven distribution leads to loosening [11]. Understanding the role of fixation zones allows us to create a methodology of conduct. The components should be firmly seated with a proper distribution of mechanical forces, which is a decisive success factor. Lack of uniform load leads to movements exceeding 150 μm, which stimulates the formation of soft tissue, preventing implant osteointegration [12]. Methods of treating bone defects have been described in detail in the literature, especially during the short- and medium-term follow-up period. Smaller, closed defects can be treated with a bone substitute or bone cement, whereas the larger ones can be treated with bolt-reinforced cement or modular metal parts. The joint surface defects require the use of structural grafts or metal implants [5]. The evolution of materials has contributed to the development of porous surfaces that improve mechanical stability. To provide a structural and biomechanical reconstruction of the metaphyseal area, titanium implants can be used to increase the surface area and support the remaining implants. These solutions include sleeve’s and cone’s, which are two different technologies with different philosophies. In our practice, we decided to use cones for several reasons. One of them is the independence of zone implantation, which enables the distribution of forces beyond the articular area, protecting it from excessive stresses. The fixation in the metaphyseal zone is independent of the joint surface and diaphysis zones. Ensuring the independence of the positioning of the tibial tray and the extension allows for >85% of the adjustment of the stem to the bone shaft without disturbing the mechanical axis [13]. In other cases, the fit can be achieved using a cemented stem. Another reason is the covering of the implant modeled on the structure of the trabecular bone. An average porosity of 80% combined with a modulus of elasticity, low stiffness and a high coefficient of friction increases osteoconductive, ensuring physiological load transfer and reducing the risk of loosening [14]. A great advantage of cones is the low potential for bacterial adhesion and high survival [15]. Thanks to the use of titanium alloy (Ti6Al4V), cones are characterized by high corrosion resistance, excellent biocompatibility and very good osteointegration. In addition, Allizond et al. present the ability of a Ti6Al4V surface nanotexture to limit bacterial adhesion, compared to a mirror-polished control, even without the addition of silver [16]. All these features translate into the longevity of the implants. Bonanzinga et al. conducted a meta-analysis of 432 implanted cones with an average follow-up of 42 months. Features of loosening were shown by 1.15% [17].

Figure 2 
               Intraoperative view of 3D printed Cone auguments; (a) Total reconstruction of the condyle in the metaphyseal zone of the tibia. The outer layer of the implant provides high porosity, which translates into a friction increase in osteoconductive. (b and c) The use of the peripheral Cone to rebuild the tibial surface resigning from the use of a tibial augment; (d) The example of femoral Cone where broken bone fragments with ligament attachments were based on the implant.
Figure 2

Intraoperative view of 3D printed Cone auguments; (a) Total reconstruction of the condyle in the metaphyseal zone of the tibia. The outer layer of the implant provides high porosity, which translates into a friction increase in osteoconductive. (b and c) The use of the peripheral Cone to rebuild the tibial surface resigning from the use of a tibial augment; (d) The example of femoral Cone where broken bone fragments with ligament attachments were based on the implant.

The change in bone density (on average by 27%) after primary arthroplasty was correlated with its severe loss, and it is a serious challenge in TKA revision [14]. 3D-printed titanium cones with anatomical shapes and porous structure can provide structural support while offering the potential for permanent biological fixation. The use of structural grafts has been associated with long remodeling times, limited graft availability, nonunion or resorption. Admittedly, Sandiford et al. proved comparable effectiveness in the application of both solutions; however, most reports indicate a high revision rate exceeding even 20% (over a 10-year period) [18]. The first generation of cones showed promising clinical and radiological results in TKA revisions. Their limitations were imprecise bone preparation and limited availability of sizes and shapes. The second generation offers a much wider range and safer preparation [19].

The production technique based on 3D printing allowed the creation of a wide range of sizes for high fit, based on the use of a large CT database to determine the location and shape for optimal bone coverage and support [20]. The tools adapted to the size significantly reduced the risk of uncontrolled milling without obtaining a guarantee of geometric fit and the need to use cement. Faizan et al. compared traditional and 3D-printed implants. In the case of using traditional implants, the incidence of intraoperative fractures during preparation was 4%. By analyzing movements during valgus and simulated steps, the research showed similar values for the use of central tibial cones for both technologies. In the case of asymmetrical tibial and femoral cones, they were much smaller compared to traditional [21]. The benefits of using an implant based on 3D printing were described by Patel et al., assessing the stability and radiological results from the third to the sixth month after surgery as 100% [22]. Denehy et al. performed a multicenter review of 62 TKA revisions using 3D cones, with at least 2 years of follow-up. There were no cases of aseptic loosening and the survival rate was 90.2% [20]. In both studies, the reason for the review was infections. The authors noted no signs of loosening in radiological examinations or progressive lines translucent to X-rays (after excluding patients with infection).

In this study, the mean score in the KSS questionnaire improved from 12.5 to 79.3 points. Similar results were reported by Girerd et al. [23]. Tetreault et al. also showed 98% survival over a 2-year period. The authors observed four cases of unsuccessful osseointegration [24]. Divano et al. reported 100% aseptic survival in the mean 5 years and 2% revision due to infection, treated without the need for Cone removal. At the same time, the authors indicated 96% survival of the first-generation femoral Cone in a series of 159 cases but with a 24% fracture rate. The complication rate for 3D cones was 2.1% [25]. A potential failure may be the use of cones in sclerotic bone, which is a serious obstacle to osteointegration, especially on the tibia side where the risk of loosening is greatest [14,19,24]. You et al. presented no deep infection in 17 cases with a mean follow-up of 3.5 years [26]. Our study also reported a very low rate of infections – two cases (1.2%) within the first 6 weeks after surgery.

So far, severe bone defects, classified as type 3 according to AORI, have mostly been treated with a structural graft or resection prostheses [27]. By using the multi-zone fixation technique, we believe that cones can also be effectively used in such cases. Their use allows us to raise the level of implant fixation, ensuring the correct reconstruction of the joint line, while avoiding further bone resection and sharing the load forces between the metaphyseal and join surface zones. Such an application is described by Kukreja and Swanson presenting a series of six cases (AORI type 3) using the tibial cones. Radiographic evaluation showed 100% of osteointegration recorded on final radiographs in all patients after a mean follow-up of 4.1 years [28]. Similarly, Meneghini et al. described the use of Cone implants in the reconstruction of the tibia and joint line as an effective solution for delaying the use of a respectable endoprosthesis [29]. Our experience also shows this possibility. In nine cases, we reconstructed the metaphyseal zone of the tibia using the peripheral Cone with total reconstruction of the condyle (Figure 2a). In four cases, we used the peripheral Cone to rebuild the tibial surface, resigning from the use of a tibial augment (Figure 2b and c). This decision was dictated by osteoporotic bone tissue and the belief in a more favorable, superficial force distribution into the diaphysis zone. In three patients, the broken bone fragments with ligament attachments were based on the femoral Cone and, in one case, reinforced with titan wire loops (Figure 2d). The radiological evaluation of the image over a 2-year period did not reveal any signs of loosening. Physical examination confirmed ligamentous stability with a range of motion of 0–120. In one case, we used the femoral and tibial cones to fill the defects after removing the loosened sleeves, and in another case, after removing the hinged prosthesis, which effectively allowed us to fill the defects classified as AORI 3 type. We also believe that the use of cones allows us to reduce the need to use resection prosthesis in doubtful cases. Their use allows us to rebuild the destroyed metaphyseal zone and restore the joint line. However, in the case of significant bone loss, reaching diaphysis, we recommend the use of resection prostheses with fixation in the bone shaft.

This study has limitations related to a retrospective analysis carried out on a heterogeneous group of patients. However, the effects of the retrospective nature of the study are mitigated by the prospective collection of data. It is worth adding that this is one of the few studies of a series of cases with the use of 3D cones in a large number of patients undergoing functional assessment. The use of implants was determined by surgeons with no preferred indication of a particular type. Another limitation is the imperfection of the KSS scale as a measure of clinical outcome that combines subjective outcomes with implant survival data. However, it is worth adding that it is the most frequently used classification for functional assessment of patients after TKA. Finally, the length of the observation is relatively short. However, 3D-printing Cone implants were introduced in Poland in 2017. Therefore, further monitoring of our population will provide additional information.

5 Conclusion

The use of cone implants has gained importance in the revision of the knee joint due to its biological and mechanical properties. Structural stiffness and stability due to the high coefficient of friction provide a structural reinforcement in the weaker spongy bone of the metaphyseal zone, ensuring the correct distribution of mechanical forces. Their use could reduce the risk of infection. The available literature and our experience confirm the assumption that cones is a real option in the effective treatment of bone loss classified according to AORI as type 2B and 3. Summarizing the available data, we conclude that 3D-printed cones provide good strengthening of the metaphyseal zone in the short term. These results are encouraging, although they must be confirmed by longer observation.

Acknowledgments

None.

  1. Funding information: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.

  2. Author contributions: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Daniel Kotrych, Adam Brodecki, Sławomir Marcinkowski, Marcin Anuszkiewicz and Jakub Kleszowski. The first draft of the manuscript was written by Adam Brodecki, Dawid Ciechanowicz and all authors commented on previous versions of the manuscript. Dawid Ciechanowicz and Jakub Kleszowski take part of Review and Editing process. All authors read and approved the final manuscript.

  3. Conflict of interest: The authors declare no conflicts of interest. This study has not been presented previously. This study was financed by authors’ own resources

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Hamilton DF, Howie CR, Burnett R, Simpson AH, Patton JT. Dealing with the predicted increase in demand for revision total knee arthroplasty: Challenges, risks and opportunities. Bone Joint J. 2015;97-B(6):723–8.10.1302/0301-620X.97B6.35185Search in Google Scholar PubMed

[2] Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the united states from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780–5.10.2106/JBJS.F.00222Search in Google Scholar PubMed

[3] Pitta M, Esposito CI, Li Z, Lee YY, Wright TM, Padgett DE. Failure after modern total knee arthroplasty: A prospective study of 18,065 knees. J Arthroplasty. 2018 Feb;33(2):407–14.10.1016/j.arth.2017.09.041Search in Google Scholar PubMed PubMed Central

[4] van Kempen RW, Schimmel JJ, van Hellemondt GG, Vandenneucker H, Wymenga AB. Reason for revision TKA predicts clinical outcome: Prospective evaluation of 150 consecutive patients with 2-years followup. Clin Orthop Relat Res. 2013;471(7):2296–302. 10.1007/s11999-013-2940-8.Search in Google Scholar PubMed PubMed Central

[5] Lei PF, Hu RY, Hu YH. Bone defects in revision total knee arthroplasty and management. Orthop Surg. 2019 Feb;11(1):15–24. 10.1111/os.12425. Epub 2019 Feb 27. PMID: 30809942; PMCID: PMC6430493.Search in Google Scholar

[6] Liang H, Bae JK, Park CH, Kim KI, Bae DK, Song SJ. Comparison of mode of failure between primary and revision total knee arthroplasties. Orthop Traumatol Surg Res. 2018 Apr;104(2):171–6. 10.1016/j.otsr.2017.10.003. Epub 2017 Oct 12. PMID: 29032308.Search in Google Scholar

[7] Panegrossi G, Ceretti M, Papalia M, Casella F, Favetti F, Falez F. Bone loss management in total knee revision surgery. Int Orthop. 2014 Feb;38(2):419–27. 10.1007/s00264-013-2262-1. Epub 2014 Jan 10. PMID: 24407821; PMCID: PMC3923937.Search in Google Scholar

[8] Gill UN, Ahmed N, Noor SS, Memon IA, Memon ZA. Management of the bone loss by metaphyseal sleeves in primary and revision knee arthroplasty: Clinical experience and outcome after forty three cases. Int Orthop. 2020 Nov;44(11):2315–20. 10.1007/s00264-020-04663-1. Epub 2020 Jun 17. PMID: 32556384.Search in Google Scholar

[9] Sculco PK, Abdel MP, Hanssen AD, Lewallen DG. The management of bone loss in revision total knee arthroplasty: Rebuild, reinforce, and augment. Bone Joint J. 2016 Jan;98-B(1 Suppl A):120–4. 10.1302/0301-620X.98B1.36345. PMID: 26733657.Search in Google Scholar

[10] Morgan-Jones R, Oussedik SI, Graichen H, Haddad FS. Zonal fixation in revision total knee arthroplasty. Bone Joint J. 2015 Feb;97-B(2):147–9. 10.1302/0301-620X.97B2.34144. PMID: 25628273.Search in Google Scholar

[11] Vasso M, Beaufils P, Cerciello S, Schiavone Panni A. Bone loss following knee arthroplasty: Potential treatment options. Arch Orthop Trauma Surg. 2014 Apr;134(4):543–53. 10.1007/s00402-014-1941-8. Epub 2014 Feb 12. PMID: 24519708.Search in Google Scholar

[12] Parfitt AM. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone. 2002 Jan;30(1):5–7. 10.1016/s8756-3282(01)00642-1. PMID: 11792557.Search in Google Scholar

[13] Bédard M, Cabrejo-Jones K, Angers M, Pelletier-Roy R, Pelet S. The effect of porous tantalum cones on mechanical alignment and canal-fill ratio in revision total knee arthroplasty performed with uncemented stems. J Arthroplasty. 2015 Nov;30(11):1995–8. 10.1016/j.arth.2015.05.016. Epub 2015 May 18. PMID: 26021903.Search in Google Scholar

[14] Jensen CL, Petersen MM, Schrøder HM, Lund B. Bone mineral density changes of the proximal tibia after revision total knee arthroplasty. A randomised study with the use of porous tantalum metaphyseal cones. Int Orthop. 2012 Sep;36(9):1857–63. 10.1007/s00264-012-1601-y. Epub 2012 Jun 26. PMID: 22733440; PMCID: PMC3427456.Search in Google Scholar

[15] Zhang XM, Li Y, Gu YX, Zhang CN, Lai HC, Shi JY. Ta-Coated titanium surface with superior bacteriostasis and osseointegration. Int J Nanomedicine. 2019 Nov 6;14:8693–8706. 10.2147/IJN.S218640. PMID: 31806965; PMCID: PMC6842742.Search in Google Scholar

[16] Allizond V, Comini S, Cuffini AM, Banche G. Current knowledge on biomaterials for orthopedic applications modified to reduce bacterial adhesive ability. Antibiotics (Basel). 2022;11(4):529. Published 2022 Apr 15. 10.3390/antibiotics11040529.Search in Google Scholar PubMed PubMed Central

[17] Bonanzinga T, Gehrke T, Zahar A, Zaffagnini S, Marcacci M, Haasper C. Are trabecular metal cones a valid option to treat metaphyseal bone defects in complex primary and revision knee arthroplasty? Joints. 2017 Dec 14;6(1):58–64. 10.1055/s-0037-1608950. PMID: 29675508; PMCID: PMC5906107.Search in Google Scholar

[18] Sandiford NA, Misur P, Garbuz DS, Greidanus NV, Masri BA. No difference between trabecular metal cones and femoral head allografts in revision TKA: Minimum 5-year followup. Clin Orthop Relat Res. 2017 Jan;475(1):118–24. 10.1007/s11999-016-4898-9. Erratum in: Clin Orthop Relat Res. 2018 Apr;476(4):907. PMID: 27287857; PMCID: PMC5174036.Search in Google Scholar

[19] Zanirato A, Formica M, Cavagnaro L, Divano S, Burastero G, Felli L. Metaphyseal cones and sleeves in revision total knee arthroplasty: Two sides of the same coin? complications, clinical and radiological results-a systematic review of the literature. Musculoskelet Surg. 2020 Apr;104(1):25–35. 10.1007/s12306-019-00598-y. Epub 2019 Mar 16. PMID: 30879231.Search in Google Scholar

[20] Denehy KM, Abhari S, Krebs VE, Higuera-Rueda CA, Samuel LT, Sultan AA, et al. Metaphyseal fixation using highly porous cones in revision Total knee arthroplasty: Minimum two year follow up study. J Arthroplasty. 2019 Oct;34(10):2439–43. 10.1016/j.arth.2019.03.045. Epub 2019 Mar 28. PMID: 31000405.Search in Google Scholar

[21] Faizan A, Bhowmik-Stoker M, Alipit V, Kirk AE, Krebs VE, Harwin SF, et al. Development and verification of novel porous titanium metaphyseal cones for revision total knee arthroplasty. J Arthroplasty. 2017 Jun;32(6):1946–53. 10.1016/j.arth.2017.01.013. Epub 2017 Jan 18. PMID: 28196619.Search in Google Scholar

[22] Patel NK, Kim EG, Chughtai M, Khlopas A, Elmallah RD, Harwin SF, et al. Highly porous metaphyseal cones in revision total knee arthroplasty: A case series. J Knee Surg. 2016 Nov;29(8):614–620. 10.1055/s-0036-1593369. Epub 2016 Oct 6. PMID: 27711948.Search in Google Scholar

[23] Girerd D, Parratte S, Lunebourg A, Boureau F, Ollivier M, Pasquier G, et al. Total knee arthroplasty revision with trabecular tantalum cones: Preliminary retrospective study of 51 patients from two centres with a minimal 2-year follow-up. Orthop Traumatol Surg Res. 2016 Jun;102(4):429–33. 10.1016/j.otsr.2016.02.010. Epub 2016 Apr 1. PMID: 27052939.Search in Google Scholar

[24] Tetreault MW, Perry KI, Pagnano MW, Hanssen AD, Abdel MP. Excellent two-year survivorship of 3D-printed metaphyseal cones in revision total knee arthroplasty. Bone Joint J. 2020 Jun;102–B(6_Supple_A):107–15. 10.1302/0301-620X.102B6.BJJ-2019-1544.R1. PMID: 32475272.Search in Google Scholar

[25] Divano S, Cavagnaro L, Zanirato A, Basso M, Felli L, Formica M. Porous metal cones: Gold standard for massive bone loss in complex revision knee arthroplasty? A systematic review of current literature. Arch Orthop Trauma Surg. 2018 Jun;138(6):851–63. 10.1007/s00402-018-2936-7. Epub 2018 Apr 18. PMID: 29671089.Search in Google Scholar

[26] You JS, Wright AR, Hasegawa I, Kobayashi B, Kawahara M, Wang J, et al. Addressing large tibial osseous defects in primary total knee arthroplasty using porous tantalum cones. Knee. 2019 Jan;26(1):228–39. 10.1016/j.knee.2018.11.001. Epub 2018 Dec 14. PMID: 30554910.Search in Google Scholar

[27] Kamath AF, Lewallen DG, Hanssen AD. Porous tantalum metaphyseal cones for severe tibial bone loss in revision knee arthroplasty: A five to nine-year follow-up. J Bone Joint Surg Am. 2015 Feb 4;97(3):216–23. 10.2106/JBJS.N.00540. PMID: 25653322.Search in Google Scholar

[28] Kukreja MM, Swanson TV. Can tibial tantalum cones eventually eliminate the adjuvant use of metallic augments for AORI type 2B/3 metaphyseal defects?? – A novel surgical technique and case series. Int J Surg Case Rep. 2018;53:200–6. 10.1016/j.ijscr.2018.09.028. Epub 2018 Sep 23. PMID: 30412920; PMCID: PMC6226596.Search in Google Scholar

[29] Meneghini RM, Lewallen DG, Hanssen AD. Use of porous tantalum metaphyseal cones for severe tibial bone loss during revision total knee replacement. J Bone Joint Surg Am. 2008 Jan;90(1):78–84. 10.2106/JBJS.F.01495. PMID: 18171960.Search in Google Scholar

Received: 2022-01-26
Revised: 2022-05-04
Accepted: 2022-05-05
Published Online: 2022-07-15

© 2022 Daniel Kotrych et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. AMBRA1 attenuates the proliferation of uveal melanoma cells
  3. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma
  4. Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis
  5. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis
  6. Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4
  7. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
  8. Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?
  9. The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma
  10. Gene signature to predict prognostic survival of hepatocellular carcinoma
  11. Effects of miRNA-199a-5p on cell proliferation and apoptosis of uterine leiomyoma by targeting MED12
  12. Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
  13. Is there any effect on imprinted genes H19, PEG3, and SNRPN during AOA?
  14. Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
  15. Pericentric inversion of chromosome 6 and male fertility problems
  16. Staple line reinforcement with nebulized cyanoacrylate glue in laparoscopic sleeve gastrectomy: A propensity score-matched study
  17. Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
  18. Expression of DNM3 is associated with good outcome in colorectal cancer
  19. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
  20. CRRT influences PICCO measurements in febrile critically ill patients
  21. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis
  22. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
  23. circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
  24. Prognostic value of nicotinamide N-methyltransferase in human cancers: Evidence from a meta-analysis and database validation
  25. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma
  26. A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors
  27. Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer
  28. Association between preventable risk factors and metabolic syndrome
  29. miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6
  30. Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway
  31. Quercitrin protects human bronchial epithelial cells from oxidative damage
  32. Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2
  33. circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury
  34. Sonoclot’s usefulness in prediction of cardiopulmonary arrest prognosis: A proof of concept study
  35. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation
  36. Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
  37. LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway
  38. Cx43 upregulation in HUVECs under stretch via TGF-β1 and cytoskeletal network
  39. Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey
  40. Histopathologic findings on removed stomach after sleeve gastrectomy. Do they influence the outcome?
  41. Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma
  42. Optimal diagnosis of the skin cancer using a hybrid deep neural network and grasshopper optimization algorithm
  43. miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells
  44. Clinical value of SIRT1 as a prognostic biomarker in esophageal squamous cell carcinoma, a systematic meta-analysis
  45. circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8
  46. miR-22-5p regulates the self-renewal of spermatogonial stem cells by targeting EZH2
  47. hsa-miR-340-5p inhibits epithelial–mesenchymal transition in endometriosis by targeting MAP3K2 and inactivating MAPK/ERK signaling
  48. circ_0085296 inhibits the biological functions of trophoblast cells to promote the progression of preeclampsia via the miR-942-5p/THBS2 network
  49. TCD hemodynamics findings in the subacute phase of anterior circulation stroke patients treated with mechanical thrombectomy
  50. Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid
  51. Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
  52. circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis
  53. Human amniotic fluid as a source of stem cells
  54. lncRNA NONRATT013819.2 promotes transforming growth factor-β1-induced myofibroblastic transition of hepatic stellate cells by miR24-3p/lox
  55. NORAD modulates miR-30c-5p-LDHA to protect lung endothelial cells damage
  56. Idiopathic pulmonary fibrosis telemedicine management during COVID-19 outbreak
  57. Risk factors for adverse drug reactions associated with clopidogrel therapy
  58. Serum zinc associated with immunity and inflammatory markers in Covid-19
  59. The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies
  60. LncRNA expression in idiopathic achalasia: New insight and preliminary exploration into pathogenesis
  61. Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway
  62. Moscatilin suppresses the inflammation from macrophages and T cells
  63. Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin
  64. Epithelial-mesenchymal transition-related genes in coronary artery disease
  65. The effect evaluation of traditional vaginal surgery and transvaginal mesh surgery for severe pelvic organ prolapse: 5 years follow-up
  66. Repeated partial splenic artery embolization for hypersplenism improves platelet count
  67. Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR
  68. Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis
  69. miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1
  70. The effect of tranexamic acid on the reduction of intraoperative and postoperative blood loss and thromboembolic risk in patients with hip fracture
  71. Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
  72. Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway
  73. A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
  74. Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization
  75. MicroRNA 322-5p reduced neuronal inflammation via the TLR4/TRAF6/NF-κB axis in a rat epilepsy model
  76. miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis
  77. Clinical characteristics of pneumonia patients of long course of illness infected with SARS-CoV-2
  78. circRNF20 aggravates the malignancy of retinoblastoma depending on the regulation of miR-132-3p/PAX6 axis
  79. Linezolid for resistant Gram-positive bacterial infections in children under 12 years: A meta-analysis
  80. Rack1 regulates pro-inflammatory cytokines by NF-κB in diabetic nephropathy
  81. Comprehensive analysis of molecular mechanism and a novel prognostic signature based on small nuclear RNA biomarkers in gastric cancer patients
  82. Smog and risk of maternal and fetal birth outcomes: A retrospective study in Baoding, China
  83. Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1
  84. β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis
  85. Possible impact of COVID-19 pandemic and lockdown on suicide behavior among patients in Southeast Serbia
  86. In vitro antimicrobial activity of ozonated oil in liposome eyedrop against multidrug-resistant bacteria
  87. Potential biomarkers for inflammatory response in acute lung injury
  88. A low serum uric acid concentration predicts a poor prognosis in adult patients with candidemia
  89. Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
  90. ALKBH5 inhibits TNF-α-induced apoptosis of HUVECs through Bcl-2 pathway
  91. Risk prediction of cardiovascular disease using machine learning classifiers
  92. Value of ultrasonography parameters in diagnosing polycystic ovary syndrome
  93. Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC
  94. Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis
  95. Protective effects of glaucocalyxin A on the airway of asthmatic mice
  96. Overexpression of miR-100-5p inhibits papillary thyroid cancer progression via targeting FZD8
  97. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation
  98. Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
  99. Identification of osteoporosis based on gene biomarkers using support vector machine
  100. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis
  101. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
  102. Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas
  103. LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma
  104. The perinatal factors that influence the excretion of fecal calprotectin in premature-born children
  105. Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study
  106. Does the use of 3D-printed cones give a chance to postpone the use of megaprostheses in patients with large bone defects in the knee joint?
  107. lncRNA HAGLR modulates myocardial ischemia–reperfusion injury in mice through regulating miR-133a-3p/MAPK1 axis
  108. Protective effect of ghrelin on intestinal I/R injury in rats
  109. In vivo knee kinematics of an innovative prosthesis design
  110. Relationship between the height of fibular head and the incidence and severity of knee osteoarthritis
  111. lncRNA WT1-AS attenuates hypoxia/ischemia-induced neuronal injury during cerebral ischemic stroke via miR-186-5p/XIAP axis
  112. Correlation of cardiac troponin T and APACHE III score with all-cause in-hospital mortality in critically ill patients with acute pulmonary embolism
  113. LncRNA LINC01857 reduces metastasis and angiogenesis in breast cancer cells via regulating miR-2052/CENPQ axis
  114. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer
  115. SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
  116. Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
  117. Treatment and outcomes of mechanical complications of acute myocardial infarction during the Covid-19 era: A comparison with the pre-Covid-19 period. A systematic review and meta-analysis
  118. Neonatal stroke surveillance study protocol in the United Kingdom and Republic of Ireland
  119. Oncogenic role of TWF2 in human tumors: A pan-cancer analysis
  120. Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis
  121. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
  122. TGF-β1 upregulates Sar1a expression and induces procollagen-I secretion in hypertrophic scarring fibroblasts
  123. Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
  124. NK-cell dysfunction of acute myeloid leukemia in relation to the renin–angiotensin system and neurotransmitter genes
  125. The effect of dilution with glucose and prolonged injection time on dexamethasone-induced perineal irritation – A randomized controlled trial
  126. miR-146-5p restrains calcification of vascular smooth muscle cells by suppressing TRAF6
  127. Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
  128. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
  129. Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models
  130. lncRNA FAM230B is highly expressed in colorectal cancer and suppresses the maturation of miR-1182 to increase cell proliferation
  131. circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis
  132. LncRNA SNHG3 promoted cell proliferation, migration, and metastasis of esophageal squamous cell carcinoma via regulating miR-151a-3p/PFN2 axis
  133. Risk perception and affective state on work exhaustion in obstetrics during the COVID-19 pandemic
  134. lncRNA-AC130710/miR-129-5p/mGluR1 axis promote migration and invasion by activating PKCα-MAPK signal pathway in melanoma
  135. SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53
  136. Xylooligosaccharides and aerobic training regulate metabolism and behavior in rats with streptozotocin-induced type 1 diabetes
  137. Serpin family A member 1 is an oncogene in glioma and its translation is enhanced by NAD(P)H quinone dehydrogenase 1 through RNA-binding activity
  138. Silencing of CPSF7 inhibits the proliferation, migration, and invasion of lung adenocarcinoma cells by blocking the AKT/mTOR signaling pathway
  139. Ultrasound-guided lumbar plexus block versus transversus abdominis plane block for analgesia in children with hip dislocation: A double-blind, randomized trial
  140. Relationship of plasma MBP and 8-oxo-dG with brain damage in preterm
  141. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma
  142. Delayed femoral vein ligation reduces operative time and blood loss during hip disarticulation in patients with extremity tumors
  143. The expression of ASAP3 and NOTCH3 and the clinicopathological characteristics of adult glioma patients
  144. Longitudinal analysis of factors related to Helicobacter pylori infection in Chinese adults
  145. HOXA10 enhances cell proliferation and suppresses apoptosis in esophageal cancer via activating p38/ERK signaling pathway
  146. Meta-analysis of early-life antibiotic use and allergic rhinitis
  147. Marital status and its correlation with age, race, and gender in prognosis of tonsil squamous cell carcinomas
  148. HPV16 E6E7 up-regulates KIF2A expression by activating JNK/c-Jun signal, is beneficial to migration and invasion of cervical cancer cells
  149. Amino acid profiles in the tissue and serum of patients with liver cancer
  150. Pain in critically ill COVID-19 patients: An Italian retrospective study
  151. Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
  152. Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
  153. Long non-coding RNAs LINC00689 inhibits the apoptosis of human nucleus pulposus cells via miR-3127-5p/ATG7 axis-mediated autophagy
  154. The relationship between oxygen therapy, drug therapy, and COVID-19 mortality
  155. Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: Trial mimicking with retrospective data
  156. SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
  157. The role of Shunaoxin pills in the treatment of chronic cerebral hypoperfusion and its main pharmacodynamic components
  158. TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
  159. Associations between morphokinetic parameters of temporary-arrest embryos and the clinical prognosis in FET cycles
  160. Long noncoding RNA WT1-AS regulates trophoblast proliferation, migration, and invasion via the microRNA-186-5p/CADM2 axis
  161. The incidence of bronchiectasis in chronic obstructive pulmonary disease
  162. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
  163. Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
  164. Comparison of hospitalized patients with severe pneumonia caused by COVID-19 and influenza A (H7N9 and H1N1): A retrospective study from a designated hospital
  165. lncRNA ZFAS1 promotes intervertebral disc degeneration by upregulating AAK1
  166. Pathological characteristics of liver injury induced by N,N-dimethylformamide: From humans to animal models
  167. lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
  168. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis
  169. Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer
  170. MGST1 alleviates the oxidative stress of trophoblast cells induced by hypoxia/reoxygenation and promotes cell proliferation, migration, and invasion by activating the PI3K/AKT/mTOR pathway
  171. Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1
  172. circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis
  173. EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways
  174. Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
  175. miRNA-130a-3p targets sphingosine-1-phosphate receptor 1 to activate the microglial and astrocytes and to promote neural injury under the high glucose condition
  176. Review Articles
  177. Current management of cancer pain in Italy: Expert opinion paper
  178. Hearing loss and brain disorders: A review of multiple pathologies
  179. The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
  180. Amyotrophic lateral sclerosis and delayed onset muscle soreness in light of the impaired blink and stretch reflexes – watch out for Piezo2
  181. Interleukin-35 in autoimmune dermatoses: Current concepts
  182. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
  183. Advantages of ketamine in pediatric anesthesia
  184. Congenital adrenal hyperplasia. Role of dentist in early diagnosis
  185. Migraine management: Non-pharmacological points for patients and health care professionals
  186. Atherogenic index of plasma and coronary artery disease: A systematic review
  187. Physiological and modulatory role of thioredoxins in the cellular function
  188. Case Reports
  189. Intrauterine Bakri balloon tamponade plus cervical cerclage for the prevention and treatment of postpartum haemorrhage in late pregnancy complicated with acute aortic dissection: Case series
  190. A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice
  191. Unusual neurological manifestations of bilateral medial medullary infarction: A case report
  192. Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene
  193. A case report of dermatomyositis with the missed diagnosis of non-small cell lung cancer and concurrence of pulmonary tuberculosis
  194. A rare case of endometrial polyp complicated with uterine inversion: A case report and clinical management
  195. Spontaneous rupturing of splenic artery aneurysm: Another reason for fatal syncope and shock (Case report and literature review)
  196. Fungal infection mimicking COVID-19 infection – A case report
  197. Concurrent aspergillosis and cystic pulmonary metastases in a patient with tongue squamous cell carcinoma
  198. Paraganglioma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation
  199. Lineage switch from lymphoma to myeloid neoplasms: First case series from a single institution
  200. Trismus during tracheal extubation as a complication of general anaesthesia – A case report
  201. Simultaneous treatment of a pubovesical fistula and lymph node metastasis secondary to multimodal treatment for prostate cancer: Case report and review of the literature
  202. Two case reports of skin vasculitis following the COVID-19 immunization
  203. Ureteroiliac fistula after oncological surgery: Case report and review of the literature
  204. Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report
  205. Huge mucinous cystic neoplasms with adhesion to the left colon: A case report and literature review
  206. Commentary
  207. Commentary on “Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma”
  208. Rapid Communication
  209. COVID-19 fear, post-traumatic stress, growth, and the role of resilience
  210. Erratum
  211. Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
  212. Erratum to “Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study”
  213. Erratum to “lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2”
  214. Retraction
  215. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  216. Retraction to “miR-519d downregulates LEP expression to inhibit preeclampsia development”
  217. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part II
  218. Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2022-0494/html
Scroll to top button